Skip to main content
. Author manuscript; available in PMC: 2014 Nov 21.
Published in final edited form as: J Clin Pharmacol. 2010 Nov 23;51(9):1264–1275. doi: 10.1177/0091270010382021

Table 4.

Tracheal aspirate cytokine concentrations pre- and post-azithromycin therapy*

Cytokine Pre-dose
(N=12)
D2 post-dose
(N=9)
IL-6 (pg/mL) 204
(92–444)
148
(67–255)
IL-6 Ureaplasma positive 237
(128–400)
147
(67–255)
IL-6 Ureaplasma negative 107
(76–1070)
148
(64–721)
IL-8 (pg/mL) 4560
(1980–6595)
2910
(2250–5850)
IL-8 Ureaplasma positive 5850
(2140–-5850)
3110
(2220–5850)
IL-8 Ureaplasma negative 2700
(1820–14200)
2750
(2250–8170)
IL-1β (pg/mL) 20.14
(2–89)
40.4
(25–91)
IL-1β Ureaplasma positive 24
(2–95)
63
(25–599)
IL-1β Ureaplasma negative 4
(2–82)
30
(5–91)
MPO (units/mg protein) 0.6
(0.3–1.5)
0.5
(0.3–0.8)
MPO Ureaplasma positive 0.6
(0.3–2.0)
1.2
(0.2–3.0)
MPO Ureaplasma negative 0.5
(0.3–1.2)
0.5
(0.1–0.8)
*

Data are expressed as median with 25th to 75th percentiles in parentheses